GMASSURE Launch and Awareness Raising Symposium

The GMASSURE Launch and Awareness Raising Symposium was held on the 2nd and 3rd July 2014 in Centurion (Gauteng, South Africa). Presentations from the event can be accessed below.

Presentations Day 1:

  1. Welcome, Overview and Introduction to GMASSURE Activities_ Dr John Becker
  2. Importance of Biosafety Regulation and Risk Analysis_ Dr Alex Owusu-Biney
  3. A regulator’s perspective of GM biosafety- why, what and who_ Mr Ben Durham
  4. Crop biosafety in South Africa- problems, solutions, level of awareness and the role of Biosafety SA_Dr Hennie Groenewald
  5. Agricultural Biotechnology in the Bioeconomy – the importance of GM crops in Southern Africa_Dr Manshree Jugmoham-Naidu
  6. Experiences in sub-Saharan Africa with GM crop risk communication_Dr Dennis Ndolo Obonyo

Presentations Day 2:

Representative on SAAMS

 

 

Prof Ian Dubery

The (Metabolomics) community have unanimously nominated Prof Ian Dubery from the Department of Biochemistry as the South African Association for Mass Spectrometry (SAAMS) Metabolomics  representative.

The South African Association for Mass Spectrometry (SAAMS) is the mass spectrometry subdivision of the South African Chemical Institute. As a non-profit organization its functions are to coordinate mass spectrometry in Southern Africa and to create and maintain an official body for the mass spectrometry technique interest and application group. SAAMS mediates the presentation of research and development in mass spectrometry. New developments and new instrumentation in mass spectrometry are introduced to the group and users and instrument suppliers are brought together.

The SAAMS target group is wide, from students, novel and inexperienced mass spectrometrists to experienced academics and industry based scientists.

Story by: UJ Science News, 2014

ACGT Represented at Joint EDULINK, ACP S&T and CP-RSD Stakeholder Conference

ACGT Centre Manager, John Becker, recently attended the joint ACP stakeholders meeting in Brussels, Belgium. The ACGT were awarded funds for an ACP-EU action “GMASSURE” (Assuring agricultural and food safety of Genetically Modified Organisms in Southern Africa) for the 2014-2016 period.

Below is an excerpt of the event from the ACP-EU Science and Technology website:

On 1-2 April 2014, the ACP Secretariat hosted at the ACP House in Brussels the first joint stakeholder’s conference ‘Investing in the knowledge economy within ACP states’ for three key ACP-EU Programmes financed primarily from the 10th European Development Fund (EDF) – ‘EDULINK II’, ‘ACP Science and Technology Programme II’ and the ‘ACP Caribbean & Pacific Research Programme for Sustainable Development’.

The agenda was structured over two days with general sessions and some sessions specifically targeted to EDULINK (47 projects) or to ACP S&T II (21 projects) and the ACP CP-RSD (10 projects). Information on all these projects were presented in a booklet.

The total number of participants was 188, of which 171 represented the projects of the three programmes. There were 107 participants from EDULINK projects, 43 participants from ACP-S&T projects and 21 participants from ACP CP-RSD projects. Other 17 participants came from embassies, the Technical Assistance Units (TAUs), the ACP Secretariat and the EC’s directorate DEVCO.

The conference was to foster networking and co-operation among grant beneficiaries of the three programmes so as to establish contacts, share experiences, discuss plans and future collaborations, and gain knowledge on appropriately managing their projects. Emphasis was given to general topics (financial management, project management) and to sectorial or technical issues (curriculum development, ICT, policy maker involvement, innovation).

After the plenary opening of the conference and the introduction of the projects, parallel sessions were organized to generate discussions among participants and exchange experiences and ideas on topics relevant to EDULINK (Joint curricula development and accreditation in the ACP HEIs; ICT and distance learning: challenges and opportunities for ACP HEIs or to ACP S&T and ACP CP-RSD (From project to policy: the involvement of policy makers; Translating capacity building and research into innovation).

On the second day, a presentation was given on the Overview of contractual documents, followed by parallel sessions on topics relevant to all three programmes:  Contract financial and reporting rules and Project management.

Outside the conference rooms, participants could pass by posters and flyers of the projects to discuss technical aspects amongst themselves.

The conference was closed by a presentation and discussion on Horizon 2020.

The participants expressed as most interesting the interactive sessions on both technical and grant management issues, but more time should be spent on these sessions in future occasions.

For more information visit:

http://www.acp-st.eu/

 

Innovation Hub’s Biopark to open in third quarter

Phase 1 of the Innovation Hub’s Biopark@Gauteng is already filled to capacity, says Innovation Hub research, development and innovation GM Dr Boitumelo Semete-Makokotlela.

The ten companies in Phase 1 of the Life Sciences Enterprise project will be able to move into the park in the third quarter of this year.

Construction work on the office and manufacturing space, located at the Innovation Hub, in Tshwane, is almost complete.

Phase 1 will also house the Innovation Hub’s Climate Innovation Centre (CIC), which accommodates an additional 20, precommercial companies.

The aim of the Biopark is to accelerate the commercialisation of biotechnology in South Africa, in support of the Department of Science and Technology’s bio-economy strategy, as well as to address key aspects of the Gauteng Innovation and Knowledge Economy Strategy, says Semete-Makokotlela.

“Biotechnology can only contribute to the country’s gross domestic product if innovations stemming from the sector can be commercialised.”

Semete-Makokotlela says the Biopark was conceptualised by Innovation Hub CEO McLean Sibanda during the 2011/12 financial year.

“The Innovation Hub was previously very much focused on information and communication technology, and the construction of the Biopark and the establishment of the CIC signal an expansion into the bio- and green economy sectors,” says Semete-Makokotlela.

“Barriers to entry in these sectors tend to include access to infrastructure, such as manufacturing facilities, laboratories and equipment that can service small and medium biotechnology enterprises. Universities are more focused on research and development, and not commercialisation. Hence, the new development at the Innovation Hub will significantly contribute towards the acceleration of small- and medium biotechnology enterprises.

“Our main intent is to create an enabling environment for the growth and commercialisation of biotechnology innovations. We hope the park creates an ecosystem where like-minded people can collaborate.”

Once the feasibility study and the business plan on the Biopark, funded by the Gauteng Department of Agriculture and Rural Development, were complete, the Innovation Hub was left with the task to source funding for the project.

The initial plan was to secure R300-million, but the tepid economic climate saw the hub scale down its ambitions, while also dividing its development plan into phases.

The Gauteng Growth and Development Agency and the Department of Trade and Industry provided funding for Phase 1 and some development aspects of phase 2, with R70-million required for the development of both phases of the project.

Phase 1’s Life Sciences Enterprise Project will house companies in the agroprocessing, medical devices and diagnostics industries.

The CIC, in turn, is focused on the green economy, and specifically on “innovative, new technologies,” explains Semete-Makokotlela.

“So, yes, it can be solar panels, but then we want a new, innovative manufacturing technique.”

“We provide office and manufacturing space,” she adds. “The rental rates are highly subsidised.”

The companies housed within the Biopark and the CIC also receive a mentor, as well as help to access the market and to develop an intellectual property strategy.

The hub has partnered with eGoLiBio to assist with these matters. eGoLiBio serves as a partner incubator for the commercialisation of bioscience products.

Semete-Makokotlela expects construction on Phase 2 of the Biopark  to start early next year.

The second phase will house companies in the ‘cosmeceutical’ and biopharmaceutical industries.

Phase 1 has 800 m2 office space, and 500 m2 manufacturing space. Phase 2 will be 1 600 m2 in size.

Story by: Irma Venter, From Creamer Media’s Engineering News at www.engineeringnews.co.za